T1	Condition 745 773	enterobacteriaceae infection
T2	Condition-Name 745 773	enterobacteriaceae infection
E1	Condition:T1 Name:T2 Stage:E42
T3	Condition 787 815	enterobacteriaceae infection
T4	Condition-Name 787 815	enterobacteriaceae infection
E3	Condition:T3 Name:T4
T5	Condition 392 413	anaphylactic reaction
T6	Condition-Name 392 413	anaphylactic reaction
E5	Condition:T5 Name:T6
T7	Condition 627 648	Pseudomonas infection
T8	Condition-Name 627 648	Pseudomonas infection
E7	Condition:T7 Name:T8
T9	Condition 663 684	Pseudomonas infection
T10	Condition-Name 663 684	Pseudomonas infection
E9	Condition:T9 Name:T10
T11	Condition 589 602	breastfeeding
T12	Condition-Name 589 602	breastfeeding
E11	Condition:T11 Name:T12
T13	Eq-Operator 29 30	≥
A1	Eq-Operator-Value T13 GTEQ
T14	Eq-Temporal-Unit 34 39	years
A2	Eq-Temporal-Unit-Value T14 year
T15	Age 25 28	Age
E12	Age:T15 Eq-Comparison:E14
T17	Eq-Value 31 33	18
T19	Eq-Comparison 29 39	≥ 18 years
E14	Eq-Comparison:T19 Operator:T13 Temporal-Unit:T14 Value:T17
T20	Eq-Comparison 350 357	History
E15	Eq-Comparison:T20 Temporal-Period:T21
T21	Eq-Temporal-Period 350 357	History
A3	Eq-Temporal-Period-Value T21 past
T16	Drug 64 74	antibiotic
E2	Drug:T16 Name:T22
T22	Drug-Name 64 74	antibiotic
T23	Procedure 75 84	treatment
E4	Procedure:T23 
R1	Using Arg1:E4 Arg2:E2	
T24	Indication 49 59	Indication
E6	Indication:T24 Indication-For:E4
T18	Drug 118 131	cephalosporin
E8	Drug:T18 Name:T25
T25	Drug-Name 118 131	cephalosporin
T26	Modifier 92 117	3rd generation injectable
E10	Modifier:T26 Modifies:T25
R2	Using Arg1:E4 Arg2:E8	
T27	Drug 133 143	cefotaxime
E13	Drug:T27 Name:T28
T28	Drug-Name 133 143	cefotaxime
R3	Example-Of Arg1:E13 Arg2:E8	
T29	Drug 147 158	ceftriaxone
E16	Drug:T29 Name:T30
T30	Drug-Name 147 158	ceftriaxone
T31	Or 144 146	or
E17	Or:T31 Arg:E13 Arg2:E16
R4	Example-Of Arg1:E16 Arg2:E8	
T32	Condition 214 230	Hypersensitivity
E18	Condition:T32 Name:T33
T33	Condition-Name 214 230	Hypersensitivity
T34	Drug 234 245	ceftriaxone
E19	Drug:T34 Name:T35
T35	Drug-Name 234 245	ceftriaxone
T36	Drug 249 259	cefotaxime
E20	Drug:T36 Name:T37
T37	Drug-Name 249 259	cefotaxime
T38	Or 246 248	or
E21	Or:T38 Arg:E19 Arg2:E20
R5	Caused-By Arg1:E18 Arg2:E19	
R6	Caused-By Arg1:E18 Arg2:E20	
T39	Drug 272 285	cephalosporin
E22	Drug:T39 Name:T40
T40	Drug-Name 272 285	cephalosporin
T41	Other 264 271	another
E23	Other:T41 Is-Other:E22
R7	Caused-By Arg1:E18 Arg2:E22	
T42	Condition 368 384	hypersensitivity
E24	Condition:T42 Name:T43 Severity:T44 Temporality:E15
T43	Condition-Name 368 384	hypersensitivity
T44	Severity 361 367	severe
A4	Severity-Value T44 severe
R8	Example-Of Arg1:E5 Arg2:E24	
T45	Drug 435 454	antibacterial agent
E25	Drug:T45 Name:T46
T46	Drug-Name 435 454	antibacterial agent
T47	Modifier 462 473	beta-lactam
E26	Modifier:T47 Modifies:T46
R9	Caused-By Arg1:E24 Arg2:E25	
T48	Other 418 425	another
E27	Other:T48 Is-Other:E25
T49	Drug 482 493	penicillins
E28	Drug:T49 Name:T50
T50	Drug-Name 482 493	penicillins
T51	Drug 495 506	monobactams
E29	Drug:T51 Name:T52
T52	Drug-Name 495 506	monobactams
T53	Drug 511 521	carbapenes
E30	Drug:T53 Name:T54
T54	Drug-Name 511 521	carbapenes
T55	Or 507 510	and
E31	Or:T55 Arg:E29 Arg2:E30
R10	Example-Of Arg1:E28 Arg2:E25	
R11	Example-Of Arg1:E29 Arg2:E25	
R12	Example-Of Arg1:E30 Arg2:E25	
T56	Drug 559 570	ceftriaxone
E32	Drug:T56 Name:T57
T57	Drug-Name 559 570	ceftriaxone
T58	Modifier 528 540	Subcutaneous
E33	Modifier:T58 Modifies:T57
T59	Condition 576 584	Pregnant
E34	Condition:T59 Name:T60
T60	Condition-Name 576 584	Pregnant
T61	Life-Stage-And-Gender 603 608	woman
A5	Life-Stage-And-Gender-Type T61 female
R13	If-Then Arg1:T61 Arg2:E11	
T62	Or 585 588	and
E35	Or:T62 Arg:E34 Arg2:E11
T63	Assertion 614 623	Suspicion
E36	Assertion:T63 Asserted:E7
A6	Assertion-Type-Value E36 possible
T64	Or 649 651	or
E37	Or:T64 Arg:E7 Arg2:E9
T65	Procedure 707 716	treatment
E38	Procedure:T65 
T66	Drug 695 706	ceftazidime
E39	Drug:T66 Name:T67
T67	Drug-Name 695 706	ceftazidime
R14	Using Arg1:E38 Arg2:E39	
T68	Assertion 685 694	requiring
E40	Assertion:T68 Asserted:E39
A7	Assertion-Type-Value E40 hypothetical
R15	Treatment-For Arg1:E38 Arg2:E9	
T69	Assertion 722 731	Suspicion
E41	Assertion:T69 Asserted:E1
A8	Assertion-Type-Value E41 possible
T70	Eq-Comparison 735 744	group III
E42	Eq-Comparison:T70 Unit:T71 Value:T72
T71	Eq-Unit 735 740	group
T72	Eq-Value 741 744	III
T73	Eq-Comparison 777 786	group III
E43	Eq-Comparison:T73 Unit:T74 Value:T75
T74	Eq-Unit 777 782	group
T75	Eq-Value 783 786	III
T76	Or 774 776	or
E44	Or:T76 Arg:E1 Arg2:E3
T77	Procedure 835 844	treatment
E45	Procedure:T77 
T78	Drug 826 834	cefepime
E46	Drug:T78 Name:T79
T79	Drug-Name 826 834	cefepime
R16	Using Arg1:E45 Arg2:E46	
R17	Treatment-For Arg1:E45 Arg2:E3	
